Join
Live feed
·
PRReleasevia Quantisnow
TNF Pharmaceuticals Inc. logo

TNF Pharmaceuticals Collaborates with DADA2 Foundation for Compassionate Use Study of Isomyosamine in Rare Pediatric Autoinflammatory Disease

ByQuantisnow·Wall Street's wire, on your screen.
TNFA· TNF Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TNFA (TNF Pharmaceuticals Inc.) and more on Quantisnow.